Hyperthyroidism: A rare cause of pulmonary embolism: Report of two cases
Authors:
Open Access
- 1 November 2013
- journal article
- case report-with-review-of-literature
- Published by Wolters Kluwer Health in Indian Journal of Endocrinology and Metabolism
- Vol. 17 (6) , 1104-1107
Abstract
Several disorders of coagulation and fibrinolysis have been widely reported in patients with hyperthyroidism. Most reports have focused on only the venous thromboembolism risk, and few of them have studied specifically the association between hyperthyroidism and pulmonary embolism (PE). We report two cases of Graves’ disease complicated by PE. The first patient is a 32 year-old man, and the second patient is a 23-year-old female. PE was suspected on the basis of pulmonary hypertension in patient one, and clinical presentation in the other patient. The first patient had also right heart failure. PE was confirmed in both patients by a lung perfusion-ventilation scan test. Thrombophilia screen revealed normal findings in the first patient and an elevation in coagulation factor VIII in the second one. Both patients received heparin, followed by oral anticoagulant therapy. In addition, they were treated with radioactive iodine resulting in partial recovery from hyperthyroidismforpatient oneand clinical euthyroidism for patient two. The former died of acute heart failure secondary to a chest infection, while the later was lost to follow-up. In conclusion, hyperthyroidism is associated with increased risk of venous thromboembolism, including PE. Potential mechanisms involved in this association include endothelial dysfunction, decreased fibrinolytic activity, and increased coagulation factors levels. Thyroid evaluation is recommended in patients with unprovoked venous thromboembolic events. Conversely, the diagnosis of venous thromboembolism should be considered in patients with hyperthyroidism, particularly if additional prothrombotic risk factors are present.Keywords
This publication has 29 references indexed in Scilit:
- Alterations in coagulation and fibrinolysis after levothyroxine exposure in healthy volunteers: a controlled randomized crossover studyJournal of Thrombosis and Haemostasis, 2011
- Thyroid Disorders and HypercoagulabilitySeminars in Thrombosis and Hemostasis, 2011
- Hyperthyroidism is associated with shortened APTT and increased fibrinogen values in a general population of unselected outpatientsJournal of Thrombosis and Thrombolysis, 2008
- Thyroid Dysfunction and Effects on Coagulation and Fibrinolysis: A Systematic ReviewThe Journal of Clinical Endocrinology & Metabolism, 2007
- Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activityClinical Endocrinology, 2006
- Virchow’s Triad Revisited: Abnormal FlowPathophysiology of Haemostasis and Thrombosis, 2003
- The Epidemiology of Venous ThromboembolismCirculation, 2003
- Blood coagulation and fibrinolysis in patients with hyperthyroidismJournal of Endocrinological Investigation, 2002
- Effect of Thyroid Hormones on Plasma Protein Concentrations in ManThe Journal of Clinical Endocrinology & Metabolism, 1986
- Factor VIII activity in normal volunteers receiving oral thyroid hormone.1983